A detailed history of Global Financial Private Client, LLC transactions in Novartis Ag stock. As of the latest transaction made, Global Financial Private Client, LLC holds 582 shares of NVS stock, worth $61,499. This represents 0.03% of its overall portfolio holdings.

Number of Shares
582
Previous 258 125.58%
Holding current value
$61,499
Previous $27.5 Million 143.72%
% of portfolio
0.03%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$106.13 - $120.89 $34,386 - $39,168
324 Added 125.58%
582 $66.9 Million
Q1 2023

May 15, 2024

BUY
$80.03 - $92.81 $20,647 - $23,944
258 New
258 $23.9 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Global Financial Private Client, LLC Portfolio

Follow Global Financial Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.